Please login to the form below

Not currently logged in


This page shows the latest FDA news and features for those working in and with pharma, biotech and healthcare.

New dosing option for AZ’s Imfinzi approved in the EU and UK

New dosing option for AZ’s Imfinzi approved in the EU and UK

The four-week fixed-dose schedule for Imfinzi in NSCLC was also recently approved by the US Food and Drug Administration (FDA). ... The FDA also approved the additional dosing option for patients with previously treated advanced bladder cancer.

Latest news

More from news
Approximately 732 fully matching, plus 2,840 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 2 fully matching, plus 154 partially matching documents found.

Latest appointments

More from appointments
Approximately 6 fully matching, plus 43 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 3 fully matching, plus 54 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company

Seven Stones is a creative, independent healthcare communications agency of movers and thinkers. We've been doing health differently since 1991....

Latest intelligence

2020 - a year to remember or forget?
2020 and the Covid pandemic brought immense challenges, and the need for change felt like it happened overnight. What have we learned and what does the future of agency working...
Gilead Headquarters
The search for effective drug treatments for COVID-19
PME talks to Julian Cole, Senior Director, Medical Affairs at Gilead Sciences...
PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...